Skip to content

Clinical observation of the effect of mental stress stimulation on the occurrence and development of gastrointestinal tumors

Clinical observation of the effect of mental stress stimulation on the occurrence and development of gastrointestinal tumors

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400089168
Enrollment
Unknown
Registered
2024-09-03
Start date
2024-10-01
Completion date
Unknown
Last updated
2024-09-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tumor

Interventions

exposure group:none
control group:none

Sponsors

Zhangjiagang Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Exposure group: patients with gastrointestinal tumors who were assessed by clinicians for the presence of mental stress stimuli. Control group: according to the age and gender factors, corresponding to the exposure group in the ratio of 1:1, matching patients with digestive tract tumors not accompanied by mental stress stimulation. (1) Patients were of any gender and aged between 18 and 80 years; (2) Right-handedness (3) Subjects were conscious, able to understand and cooperate in completing the questionnaire, with clear responses and informed consent to the study; (4) Signed informed consent.

Exclusion criteria

Exclusion criteria: (1) Those with mood disorders due to somatic diseases or organic brain diseases; (2) Those with a history of suicide attempts, refractory depression, seizures, bipolar disorder, schizophrenia, or schizoaffective disorder; (3) Those with a positive pregnancy test; (4) Those with malignant tumors of the stomach and those who have undergone surgery for gastrointestinal diseases; (5) Those who have taken non-steroidal anti-inflammatory drugs, proton pump inhibitors, gastric mucosal protectants, and other drugs that may damage/repair the gastric mucosa in the last 6 months; (6) Long history of smoking and alcohol consumption with alcohol intake present on day 1 before enrollment; (7) Those with hepatic, renal, hematologic, pulmonary, cardiovascular, gastrointestinal, musculoskeletal, dermatologic, genitourinary, neurologic, or any other acute or chronic medical condition that limits the subject's ability to complete or participate in this clinical study; (8) Those who are participating in other clinical trials.

Design outcomes

Primary

MeasureTime frame
tumor pathology;

Secondary

MeasureTime frame
general characteristics;biochemical index;stress rating scale;

Countries

China

Contacts

Public ContactLiu Lianfang

Zhangjiagang Hospital of Traditional Chinese Medicine

zjgzy071@njucm.edu.cn+86 151 5159 3643

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026